Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Advanced Registry Search Results

Search History (1)

Search Criteria

  1. DPOH name: BOUDREAU, MICHELLE
Share this search Create an alert
Start over
Modify criteria

Refine registrations results by

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Monthly communication reports (100)
Results: 1-50 | Export
  1. Canadian Life and Health Insurance Association Inc. / Association canadienne des compagnies d'assurances de personnes inc.
    Type: In-house Organization
    Occurred: 2024-03-18
    Posted: 2024-04-15
    Designated public office holders:
    • Michelle Boudreau, Associate Assistant Deputy Minister | Health Canada (HC)
    Subject matters:
    • Health
      •
  2. Diabetes Canada / Diabète Canada
    Type: Consultant
    Lobbyist: Noah Niznick, PAA Advisory | Conseils
    Occurred: 2024-03-12
    Posted: 2024-04-15
    Designated public office holders:
    • Jade Mallette, Director of Parliamentary Affairs, Minister's Office | Health Canada (HC)
    • Michelle Boudreau, Associate Assistant Deputy Minister | Health Canada (HC)
    Subject matters:
    • Health
      •
  3. Manulife Financial Corporation / Société Financière Manuvie
    Type: In-house Corporation
    Occurred: 2024-02-28
    Posted: 2024-03-15
    Designated public office holders:
    • Dr. Stephen Lucas, Deputy Minister | Health Canada (HC)
    • Michelle Boudreau, Associate Assistant Deputy Minister, Strategic Policy Branch | Health Canada (HC)
    Subject matters:
    • Health
      •
  4. Canadian Counselling and Psychotherapy Association / L’Association canadienne de counseling et de psychothérapie - Address & Client Representative
    Type: Consultant
    Lobbyist: Laura Rinaldi, IMPACT PUBLIC AFFAIRS
    Occurred: 2024-02-13
    Posted: 2024-02-14
    Designated public office holders:
    • Michelle Boudreau, Associate Assistant Deputy Minister, Strategic Policy Branch | Health Canada (HC)
    • Ya'ara Saks, Minister of Mental Health and Addictions | House of Commons
    Subject matters:
    • Budget
    • Taxation and Finance
    • Federal-Provincial Relations
    • Health
    • Aboriginal Affairs
      •
  5. Canadian Counselling and Psychotherapy Association / Association canadienne de counseling et psychothérapie
    Type: In-house Organization
    Occurred: 2024-02-13
    Posted: 2024-02-14
    Designated public office holders:
    • Michelle Boudreau, Assistant Deputy Minister, Strategic Policy Branch | Health Canada (HC)
    • Ya'ara Saks, Minister of Mental Health and Addictions | House of Commons
    Subject matters:
    • Aboriginal Affairs
    • Taxation and Finance
    • Health
      •
  6. Cystic Fibrosis Canada / Fibrose kystique Canada
    Type: In-house Organization
    Occurred: 2024-02-05
    Posted: 2024-02-15
    Designated public office holders:
    • Michelle Boudreau, Associate Assistant Deputy Minister, Strategic Policy Branch | Health Canada (HC)
    Subject matters:
    • Health
      •
  7. Smart Health Benefits Coalition / Coalition pour des soins de santé intelligents
    Type: Consultant
    Lobbyist: Geoff Turner, Bluesky Strategy Group
    Occurred: 2024-01-24
    Posted: 2024-02-15
    Designated public office holders:
    • Michelle Boudreau, Associate Assistant Deputy Minister, Strategic Policy Branch | Health Canada (HC)
    Subject matters:
    • Health
      •
  8. Smart Health Benefits Coalition / Coalition pour des soins de santé intelligents
    Type: Consultant
    Lobbyist: Jordan Paquet, Bluesky Strategy Group
    Occurred: 2024-01-24
    Posted: 2024-02-14
    Designated public office holders:
    • Michelle Boudreau, Associate Assistant Deputy Minister, Strategic Policy Branch | Health Canada (HC)
    Subject matters:
    • Health
      •
  9. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2024-01-18
    Posted: 2024-02-12
    Designated public office holders:
    • Michelle Boudreau, Associate Assistant Deputy Minister of Health | Health Canada (HC)
    Subject matters:
    • Health
    • Industry
      •
  10. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2024-01-11
    Posted: 2024-02-12
    Designated public office holders:
    • Michelle Boudreau, Associate Assistant Deputy Minister of Health | Health Canada (HC)
    • Stephen Lucas, Deputy Minister of Health | Health Canada (HC)
    Subject matters:
    • Industry
    • Health
      •
  11. Schizophrenia Society of Canada
    Type: Consultant
    Lobbyist: Sara-Emilie Clark, Impact Public Affairs / Impact Affaires Publiques
    Occurred: 2023-12-18
    Posted: 2024-01-08
    Designated public office holders:
    • Michelle Boudreau, Associate Assistant Deputy Minister | Health Canada (HC)
    • Hon. Ya'ara Saks, Minister of Mental Health and Addictions and Associate Minister of Health | House of Commons
    • Farangies Shah, Director of Policy | Health Canada (HC)
    • Julia Duncan, Senior Policy Advisor | Health Canada (HC)
    Subject matters:
    • Research and Development
    • Health
      •
  12. Canadian Life and Health Insurance Association Inc. / Association canadienne des compagnies d'assurances de personnes inc.
    Type: In-house Organization
    Occurred: 2023-12-01
    Posted: 2024-01-03
    Designated public office holders:
    • Michelle Boudreau, Assistant Deputy Minister, Strategic Policy Branch | Health Canada (HC)
    Subject matters:
    • Health
      •
  13. University of Manitoba
    Type: In-house Organization
    Occurred: 2023-11-06
    Posted: 2023-12-15
    Designated public office holders:
    • Michelle Boudreau, Assistant Deputy minister | Health Canada (HC)
    • Stephen Lucas, Deputy Minister | Health Canada (HC)
    Subject matters:
    • Health
      •
  14. TRIUMF
    Type: In-house Organization
    Occurred: 2023-09-21
    Posted: 2023-10-16
    Designated public office holders:
    • Nipun Vats, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    • Michelle Boudreau, Assistant Deputy Minister, Strategic Policy Branch | Health Canada (HC)
    • Ranjana Sharma, Chief Scientist | Natural Resources Canada (NRCan)
    • Alejandro Adem, President | Natural Sciences and Engineering Research Council (NSERC)
    • Iain Stewart, President | National Research Council (NRC)
    Subject matters:
    • Research and Development
    • Science and Technology
      •
  15. Canadian Generic Pharmaceutical Association (CGPA) / L'Association canadienne du médicament générique (ACMG)
    Type: In-house Organization
    Occurred: 2023-09-08
    Posted: 2023-10-16
    Designated public office holders:
    • Michelle Boudreau, Associate Assistant Deputy Minister, Strategic Policy Branch | Health Canada (HC)
    Subject matters:
    • Health
    • Industry
      •
  16. Canadian Life and Health Insurance Association Inc. / Association canadienne des compagnies d'assurances de personnes inc.
    Type: In-house Organization
    Occurred: 2023-09-08
    Posted: 2023-10-16
    Designated public office holders:
    • Michelle Boudreau, Associate Assistant Deputy Minister, Strategic Policy Branch | Health Canada (HC)
    Subject matters:
    • Health
      •
  17. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-08-31
    Posted: 2023-09-18
    Designated public office holders:
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Samir Khan, Associate Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    Subject matters:
    • Health
      •
  18. Life Sciences Ontario
    Type: Consultant
    Lobbyist: Philip Delistoyanov, 3Sixty Public Affairs
    Occurred: 2023-08-31
    Posted: 2023-09-12
    Designated public office holders:
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    Subject matters:
    • Economic Development
    • Research and Development
    • Industry
    • Health
    • Science and Technology
      •
  19. Life Sciences Ontario (LSO)
    Type: In-house Corporation
    Occurred: 2023-08-31
    Posted: 2023-09-12
    Designated public office holders:
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    Subject matters:
    • Science and Technology
    • Economic Development
    • Industry
    • Research and Development
    • Health
      •
  20. Life Sciences Ontario
    Type: Consultant
    Lobbyist: WILLIAM DEMPSTER, 3Sixty Public Affairs Inc.
    Occurred: 2023-08-31
    Posted: 2023-09-15
    Designated public office holders:
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    Subject matters:
    • Health
      •
  21. Green Shield Canada
    Type: In-house Organization
    Occurred: 2023-07-25
    Posted: 2023-08-15
    Designated public office holders:
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    Subject matters:
    • Health
      •
  22. Heart and Stroke Foundation of Canada / Fondation des maladies du coeur et de l’AVC
    Type: In-house Organization
    Occurred: 2023-05-26
    Posted: 2023-06-15
    Designated public office holders:
    • Bobby Chauhan, Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Amanda Pinke, Policy Analyst, OFFICE OF PHARMACEUTICALS MANAGEMENT STRATEGIES | Health Canada (HC)
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Jennifer Boutin, Acting Director, Canada Drug Agency Transition Office | Health Canada (HC)
    Subject matters:
    • Health
      •
  23. Canadian Life and Health Insurance Association Inc. / Association canadienne des compagnies d'assurances de personnes inc.
    Type: In-house Organization
    Occurred: 2023-05-25
    Posted: 2023-06-14
    Designated public office holders:
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    Subject matters:
    • Health
      •
  24. AbbVie Corporation
    Type: In-house Corporation
    Occurred: 2023-04-24
    Posted: 2023-05-15
    Designated public office holders:
    • Suki Wong, Director General, Mental Health Directorate, Strategic Policy Branch | Health Canada (HC)
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Eric Belair, Associate Assistant Deputy Minister, Strategic Policy Branch | Health Canada (HC)
    Subject matters:
    • Industry
    • Health
      •
  25. Boehringer Ingelheim Canada Ltd.
    Type: In-house Corporation
    Occurred: 2023-04-24
    Posted: 2024-04-02
    Designated public office holders:
    • Dr. Stephen Ellis, Member of Parliament | House of Commons
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    Subject matters:
    • Health
      •
  26. Gilead Sciences Canada
    Type: In-house Corporation
    Occurred: 2023-04-24
    Posted: 2023-05-15
    Designated public office holders:
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    Subject matters:
    • Industry
    • Research and Development
    • Health
    • Science and Technology
      •
  27. Canadian Chamber of Commerce / La Chambre de commerce du Canada
    Type: In-house Organization
    Occurred: 2023-04-24
    Posted: 2023-05-15
    Designated public office holders:
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    Subject matters:
    • Health
    • Science and Technology
    • Privacy and Access to Information
    • Research and Development
      •
  28. Hoffmann-La Roche Limited
    Type: In-house Corporation
    Occurred: 2023-03-06
    Posted: 2023-04-15
    Designated public office holders:
    • Eric Belair, Associate Assistant Deputy Minister, Strategic Policy Branch, Health Canada | Innovation, Science and Economic Development Canada (ISED)
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies, Health Canada, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    Subject matters:
    • Health
      •
  29. Canadian Life and Health Insurance Association Inc. / Association canadienne des compagnies d'assurances de personnes inc.
    Type: In-house Organization
    Occurred: 2023-01-20
    Posted: 2023-02-15
    Designated public office holders:
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    Subject matters:
    • Health
      •
  30. Boehringer Ingelheim Canada Ltd.
    Type: In-house Corporation
    Occurred: 2022-12-06
    Posted: 2023-01-13
    Designated public office holders:
    • Daniel MacDonald, Director General, Drugs for Rare Diseases | Health Canada (HC)
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Michelle Mujoomdar, Director, Specialty Pharmaceuticals | Health Canada (HC)
    Subject matters:
    • Health
      •
  31. AbbVie Corporation
    Type: In-house Corporation
    Occurred: 2022-11-30
    Posted: 2022-12-15
    Designated public office holders:
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Eric Belair, Associate Assistant Deputy Minister, Strategic Policy Branch | Health Canada (HC)
    Subject matters:
    • Health
    • Industry
      •
  32. Canadian Health Coalition / Coalition canadienne de la santé
    Type: In-house Organization
    Occurred: 2022-11-24
    Posted: 2022-12-13
    Designated public office holders:
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    Subject matters:
    • Health
      •
  33. Canadian Chamber of Commerce / La Chambre de commerce du Canada
    Type: In-house Organization
    Occurred: 2022-11-21
    Posted: 2022-12-15
    Designated public office holders:
    • Michelle Boudreau, Executive Director, Strategic Policy | Health Canada (HC)
    Subject matters:
    • Employment and Training
    • Industry
      •
  34. AbbVie Corporation
    Type: In-house Corporation
    Occurred: 2022-11-07
    Posted: 2022-12-15
    Designated public office holders:
    • Michelle Mujoomdar, Director, Specialty Pharmaceuticals | Health Canada (HC)
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Samir Khan, Director, Policy Division | Health Canada (HC)
    • Daniel MacDonald, Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    Subject matters:
    • Health
    • Industry
      •
  35. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-11-04
    Posted: 2022-12-15
    Designated public office holders:
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    Subject matters:
    • Industry
      •
  36. Life Sciences Ontario (LSO)
    Type: In-house Corporation
    Occurred: 2022-11-04
    Posted: 2022-11-07
    Designated public office holders:
    • Samir Khan, Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    Subject matters:
    • Industry
    • Intellectual Property
    • Research and Development
    • Economic Development
    • Science and Technology
    • Health
      •
  37. Life Sciences Ontario
    Type: Consultant
    Lobbyist: Philip Delistoyanov, 3Sixty Public Affairs
    Occurred: 2022-11-04
    Posted: 2022-11-07
    Designated public office holders:
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Samir Khan, Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    Subject matters:
    • Research and Development
    • Science and Technology
    • Economic Development
    • Health
    • Industry
    • Intellectual Property
      •
  38. Life Sciences Ontario
    Type: Consultant
    Lobbyist: WILLIAM DEMPSTER, 3Sixty Public Affairs Inc.
    Occurred: 2022-11-04
    Posted: 2022-12-15
    Designated public office holders:
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Samir Khan, Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    Subject matters:
    • Science and Technology
    • Health
    • Regional Development
    • Industry
    • Intellectual Property
    • Economic Development
    • Research and Development
    • International Trade
      •
  39. Boehringer Ingelheim Canada Ltd.
    Type: In-house Corporation
    Occurred: 2022-10-05
    Posted: 2022-10-12
    Designated public office holders:
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Michelle Mujoomdar, Director, Specialty Pharmaceuticals | Health Canada (HC)
    Subject matters:
    • Health
      •
  40. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-09-28
    Posted: 2022-10-15
    Designated public office holders:
    • Michelle Boudreau, Executive Director, Office of Pharmaceuticals Management Strategies, Strategic Policy Branch | Health Canada (HC)
    • Michelle Mujoomdar, Director, Specialty Pharmaceuticals, Strategic Policy Branch | Health Canada (HC)
    Subject matters:
    • Research and Development
    • Health
      •
  41. Boehringer Ingelheim Canada Ltd.
    Type: In-house Corporation
    Occurred: 2022-09-13
    Posted: 2022-09-15
    Designated public office holders:
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Zachary Nixon, Senior Special Assistant Stakeholder Relations and Regional Affairs | Global Affairs Canada (GAC)
    Subject matters:
    • Health
      •
  42. Cystic Fibrosis Canada / Fibrose kystique Canada
    Type: In-house Organization
    Occurred: 2022-08-30
    Posted: 2022-09-15
    Designated public office holders:
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    Subject matters:
    • Health
      •
  43. AbbVie Corporation
    Type: In-house Corporation
    Occurred: 2022-06-24
    Posted: 2022-06-24
    Designated public office holders:
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Samir Khan, Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    Subject matters:
    • Health
    • Industry
      •
  44. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-06-24
    Posted: 2022-07-15
    Designated public office holders:
    • Michelle Boudreau, Executive Director, Office of Pharmaceuticals Management Strategies, Strategic Policy Branch | Health Canada (HC)
    Subject matters:
    • Health
    • Industry
      •
  45. Merck Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-06-24
    Posted: 2022-07-12
    Designated public office holders:
    • samir khan, Sr Advisor for Employment | Employment and Social Development Canada (ESDC)
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    Subject matters:
    • Industry
    • Health
    • Research and Development
    • Science and Technology
      •
  46. Life Sciences Ontario (LSO)
    Type: In-house Corporation
    Occurred: 2022-06-24
    Posted: 2022-07-15
    Designated public office holders:
    • Samir Khan, Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    Subject matters:
    • Taxation and Finance
    • Science and Technology
    • Budget
    • Intellectual Property
    • Research and Development
    • Industry
    • Economic Development
    • International Trade
    • Health
      •
  47. Life Sciences Ontario
    Type: Consultant
    Lobbyist: Stephanie Levee, 3Sixty Public Affairs Inc.
    Occurred: 2022-06-24
    Posted: 2022-07-15
    Designated public office holders:
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Samir Khan, Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    Subject matters:
    • Research and Development
    • Regional Development
    • International Trade
    • Science and Technology
    • Health
    • Economic Development
    • Intellectual Property
    • Industry
      •
  48. Life Sciences Ontario
    Type: Consultant
    Lobbyist: WILLIAM DEMPSTER, 3Sixty Public Affairs Inc.
    Occurred: 2022-06-24
    Posted: 2022-07-15
    Designated public office holders:
    • Samir Khan, Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    Subject matters:
    • International Trade
    • Health
    • Regional Development
    • Research and Development
    • Science and Technology
    • Economic Development
    • Industry
    • Intellectual Property
      •
  49. GlaxoSmithKline
    Type: In-house Corporation
    Occurred: 2022-06-17
    Posted: 2022-06-27
    Designated public office holders:
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    Subject matters:
    • Health
      •
  50. GlaxoSmithKline
    Type: In-house Corporation
    Occurred: 2022-06-17
    Posted: 2022-06-30
    Designated public office holders:
    • Michelle Boudreau , Executive Director, Strategic Policy Branch | Health Canada (HC)
    Subject matters:
    • Health
      •
Date Modified: